REQUEST A DEMO
Total
USD $0.00
Search more companies

Imuna Pharm, A.S. (Slovakia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Imuna Pharm, A.S. Profile Updated: April 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Imuna Pharm, A.S. is an enterprise based in Slovakia. Its main office is in Sarisske Michalany. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on June 26, 2001. There are currently 101 - 500 (2025) people employed by Imuna Pharm, A.S.. The company’s latest financial report indicates a net sales revenue drop of 17% in 2024. Its total assets decreased by 4.12% over the same period. The net profit margin of Imuna Pharm, A.S. decreased by 12.04% in 2024.

Headquarters
Jarkova, 269/17
Sarisske Michalany; Postal Code: 08222

Contact Details: Purchase the Imuna Pharm, A.S. report to view the information.

Website: http://www.imuna.sk

Basic Information
Total Employees:
Purchase the Imuna Pharm, A.S. report to view the information.
Registered Capital:
Purchase the Imuna Pharm, A.S. report to view the information.
Financial Auditors:
Purchase the Imuna Pharm, A.S. report to view the information.
Incorporation Date:
June 26, 2001
Key Executives
Purchase this report to view the information.
Chairman of the Board
Purchase this report to view the information.
Member of the Supervisory Board
Company Performance
Financial values in the chart are available after Imuna Pharm, A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-17%
Total Operating Revenue
-38.18%
Operating Profit
-4.73%
EBITDA
-15.83%
Net Profit/Loss for the Period
-5.12%
Total Assets
-4.12%
Total Equity
-93.03%
Operating Profit Margin
-11.33%
Net Profit Margin
-12.04%
Return on Equity (ROE)
-1246.62%
Debt / Equity
3359.12%
Quick Ratio
-0.12%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?